European Association for Cardiovascular Prevention and Rehabilitation’s Annual Meeting
Istanbul Congress Center (ICC) *Istanbul, TURKEY Visit the Venue to read more
The United Nations and the WHO have set an ambitious target for us all: to reduce premature mortality from noncommunicable diseases - most notably cardiovascular diseases - by 25% by the year 2025. A global goal calls for global cooperation, and we need to learn from each other on how best to help our patients – those with established cardiovascular disease and those at high risk of developing cardiovascular disease – to achieve longer and healthier lives.
fruits and veggiesEuroPRevent is a far reaching congress attracting a wide variety of medical professionals (cardiologists, young researchers, nurses and allied professions, scientists, general practitioners..) from more than 80 countries every year. Because of our network, we provide the perfect forum to communicate on the latest developments in cardiovascular disease prevention.
While we might have delegates attending from all over the world, we still recognise that there are real 'language barriers' in terms of explaining why better lifestyle choices are so crucial at such a young age.
Each year, EuroPRevent and the EACPR promote prevention through action – with Thai Chi programmes, Bike Paths, Fun Run & Fun Walks and more... Sometimes you might wonder why?
Cardiovascular disease awareness and prevention is an absolute must. The message of better and healthier lifestyle starts with the public and all partners from policy makers to medical practitioners.
The message of prevention starts when you pass it on, that is why we are counting on you!
Throughout the years, we have tried to offer our delegates ‘healthy activities’ and highlight great initiatives and work. Please see a sample of what we have done in the past:
EuroPRevent 2009 - Stockholm, Sweden: Fun Walk and Run with an entertaining early morning warm up
EuroPrevent 2010 - Prague, Czech Republic: Fun Walk and Run
EuroPRevent 2011 - Geneva, Switzerland: Pedal for your Heart Bikes and a Prevention Bus
EuroPRevent 2012 - Dublin, Ireland: Pedal for your Heart, the Path to Health (Slai na Slainte) walking route and a Thai Chi session
EuroPRevent 2013 - Rome, Italy: an original presentation from Magnus Scheving, CEO of Lazytown about better health and lifestyle approaches for families, the availability of running and walking paths at the Eucalypti Park near the congress centre
EuroPRevent 2014 - Amsterdam, Netherlands: an outreach programme with a local public school that demonstrated the benefits of healthy eating, sports and better lifestyles for parents and children alike! The event was called EACPR Joins Jump In - you can view the video and see first hand how the Association tries to reach out to its local audience in terms of education and local support.
EuroPRevent 2015 - Visit by the EACPR Board to the Lisbon Human Motricty Faculty and the Run for Health challenge that raised funds for the European Heart for Children charity.
We are currently working with the our Local Host for Istanbul 2016 to see how the EACPR can impact the local community during our congresses!
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Important information to consider when submitting your abstract:
Abstracts can be submitted via the online Abstract Submission Services only
Abstracts sent by fax or email will not be accepted.
No late submissions will be accepted.
Opening of the Online Submission Services: 24 September 2015
Submission deadline is Friday 1 January 2016, 23:59 (CET – Central European Time).
Draft Status: If you do not click on the submit button (Step 4 of the abstract submission service), your abstract will be saved in Draft Status. You will then be able to review it and submit it at a later time (but only before the deadline).
NB: Abstracts that are in draft status after the deadline cannot be processed and therefore will not be considered for selection.
Changes and corrections: Once submitted, it is not possible to make any corrections to the abstract content or information (such as Presenter details, topic, authors list etc...). The ESC is not authorized to make changes to a submission. In order to correct your abstract you must withdraw it and submit a new corrected version prior to the deadline (See below for withdrawal procedure). Note that, such replacement of your abstract is not possible after the deadline. In the case of errors in your abstract discovered after the deadline, you may indicate the correction during the presentation at the congress. However, changes will not be included in the publications. If accepted, your abstract will be published as submitted.
Withdrawal: If you want to withdraw an abstract already submitted, please notify us as quickly as possible at email@example.com stating the title and number of the abstract to be withdrawn.
Note that, withdrawals are still accepted after the submission deadline but abstracts may still appear in publications. All abstract withdrawal requests must be received in writing (via e-mail) by March 2016 to avoid publications.
STEP 1: ABSTRACT INFORMATION
Title: Maximum 200 characters typed in lower-case letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field. Do not include authors, institutions, city names, trademarks and abbreviations in the title.
Topic: Select one topic from the list of topics which best describes the content (for Abstract Evaluation). Make sure you select the appropriate topic/best matching topic as this choice will determine which graders will review your abstract. Abstracts submitted under a topic that does not match the subject matter of the abstract may be given a lower score from reviewers.
Note that in order to view the topic list, you must first select the ESC Event for which you submit your abstract (first field of the page).
Category: You must select one of the following categories under which your abstract can be best classified:
• Cardiac Rehabilitation
• Exercise Basic & Translational Research (EBTR)
• Prevention, Epidemiology & Population Science (PEP)
• Sports Cardiology
Options: You may choose to submit your abstract under one of the following options:
• No Option - Standard submission
• Young Investigator Award (YIA) – Submission for the Young Investigator Award competition. Selected abstracts will be presented orally in one of the Young Investigators Awards (YIA) sessions. Special note to YIA submitters – If you are submitting the abstract on behalf of the first author/presenter, you must enter the first author’s birth date, as this date will be the qualifying point for the option validation. Abstracts with non eligible birth dates will be automatically removed from this option and graded as “no options” abstracts. Please tick the appropriate box in the Abstract Information section.
To present your abstract in one of the following Young Investigators Awards (YIA) sessions, you must be born after May 8, 1980.
Note that by default the 1st author should be the presenter, if not, he/she needs to be able to explain his/her role in the research. Furthermore, on-site during the session, presenters will be in competition and graded under the following categories: originality, scientific content, presentation, and answers to questions – they therefore need to be good English speakers.
If your abstract is selected for a YIA session, you will receive specific instructions. Prizes will be given to the four best presentations in each session (a diploma and a prize of €500 for the winners).
We highlight the fact that only the Presenter may have a prize & diploma addressed to him/her.
On behalf of: You may use this field to enter the name of the affiliation for your research or the name of an investigating team. Do not use this field to list individual authors.
Funding Acknowledgements: All sources of financial support (including governmental grants) for this research should be listed under this heading. All grant funding agency abbreviations should be spelled out. This information will be published.
Acronyms: If the study to be presented is known through an acronym, please indicate the name of the study (e.g. "EMIT") in the appropriate field, as well as the full name of the acronym (e.g. "European Mizaverol Trial").
STEP 2: ABSTRACT AUTHORS AND INSTITUTIONS
Your abstract must list at least 1 author in order to be submitted.
Authors list:Please note that the first author should be the abstract Presenter by default. Nevertheless, it can be modified through the agreement form online available in February 2016. In all cases, the Presenter must be part of the authors list included in the submitted abstract and be able to explain his/her role in the research during presentation. You may enter up to 15 authors in the authors list including the Presenter. The names of authors will be published as listed on the submission form. Please make sure you have enter the full list of authors and that the information given for each author is correct, as no changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).
The authors’ order and details (names, cities, and country codes) will be published as entered by the submitter.
The submitter certifies that he/she has permission from all persons he/she enters as co-authors to be listed in this abstract and that they are aware that their names will appear in all publications.
If none of the authors are able to present the abstract during the congress, the abstract should be withdrawn. If not, it will be considered as no-show and the Congress Programme Committee can then decide not to consider an abstract submitted by the same author the following year.
Institutions: This is a mandatory step.
You will be requested to select your institution when you create the presenter and the authors. Once you have entered your city, a list will automatically appear from which you can select your institution.
If your institution is not in the list, you have the possibility of creating it.
If your city is not in the list, please enter it, press enter then add your institution.
STEP 3: ABSTRACT CONTENT
All abstracts must be submitted (and will be presented) in English using UK English spelling with accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker, by a university scientific publications office (or other similar facility) prior to submission.
Abstracts must contain original material neither published nor presented elsewhere prior to EuroPRevent 2016 (in print or electronically).
Abstract submitted on animal studies: Study must follow the "Principles of laboratory animal care" (NIH Publication no. 85-23 revised 1985) and according to the national law if applicable.
Do not cut and paste symbols into your text. Use the symbols provided when you click on the Ω.
We recommend you structure your abstract using the following headings:
There is not a specific maximum of words, but rather a maximum total size of the abstracts (shown as 100 %), including the text, table and picture (if any). The maximum abstract size is 35 lines of 75 characters (2625 characters including spaces)
An image represents 11 lines (including the title)
Each table row represents 1 line (+ 3 lines for title and legend)
The table legend size is calculated by dividing its numbers of characters by 75.
Use the save and refresh button at the bottom in order to display the size of the abstract in percentage (shown on the left side of the screen). The programme then converts the size in % to display to you when you register it as a draft.
The character limit does not include the title and the authors. Only the abstract text, table, picture and spaces are taken into account.
Important: As the grading and selection process is blinded, the title and body text must not contain identifying features, ie information such as:
Names (authors or other)
Names of institute (hospitals, medical schools, clinics…)
Also not authorised
Trademarks. Use generic drug names. The use of commercial drug names is strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation
Company names and location
Web sites and email addresses
Failure to comply with the above requirements will/may lead to automatic rejection of the submission or this information may be deleted by the abstract services and some rephrasing may occur.
Furthermore, the Abstract Review Committee (graders) is required to identify abstracts pertaining to commercial promotion of a proprietary product, to notify the selection committee.
Do not include grant acknowledgements in the abstract content. Use the appropriate field.
Do not cite references in the abstract, as they are not allowed and will be deleted.
Do not include copyright or trademark symbols.
Limit use of acronyms and abbreviations. Define at first use with acronym or abbreviation in parentheses.
EACPR Contact Information
Les Templiers 2035 Route des Colles CS 80179 BIOT
06903 Sophia Antipolis, France
EACPR Contact Information
Les Templiers 2035 Route des Colles CS 80179 BIOT
06903 Sophia Antipolis, France